| (AUD) | Jun 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | -100.00% |
| Operating expense | — | — |
| Net income | -15.10M | 40.77% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, OSL.AX returned +6.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +19.6% |
| 1 year | +6.4% |
| 5 years | -92.0% |
| 10 years | -97.1% |
| All-time high | $74.33 (Nov 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in OSL.AX would be worth today ›No. OncoSil Medical Limited has not paid a dividend in the past 12 months.
OncoSil Medical Limited is part of the Healthcare sector.
OncoSil Medical Limited has a market cap of 35.83M AUD, based on the latest quote.
